Trial Profile
A study to evaluate the effect of belimumab on peripheral blood cells in patients with systemic lupus erythematosus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Pharmacodynamics
- 02 Feb 2016 New trial record